GABA(B) R1 inhibitors form a distinctive chemical class of compounds meticulously designed to specifically target and block the GABA(B) R1 subunit of the GABA(B) receptor in the central nervous system. The GABA(B) receptor, a G-protein-coupled receptor, plays a crucial role in mediating inhibitory neurotransmission in the brain by responding to the neurotransmitter gamma-aminobutyric acid (GABA). These inhibitors work by binding to the GABA(B) R1 subunit, effectively hindering its function and thereby modulating the receptor's activity.
By acting as antagonists, they disrupt the GABA(B) receptor's normal response to GABA, leading to the inhibition of downstream signaling pathways associated with GABA(B) receptor activation. The inhibition of GABA(B) R1 can influence various physiological processes regulated by GABA(B) receptor-mediated neurotransmission. As valuable research tools, GABA(B) R1 inhibitors enable scientists to delve deeper into the intricate workings of the GABA(B) receptor system and gain valuable insights into its roles in different physiological and pathophysiological contexts. Through a thorough understanding of the molecular mechanisms underlying GABA(B) R1 inhibition, researchers can expand their knowledge of receptor function and explore novel avenues of investigation in neuroscience research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R-(+)-Baclofen (free base) | 69308-37-8 | sc-203228 sc-203228A | 10 mg 50 mg | $50.00 $195.00 | ||
(R)-Baclofen is an enantiomer of baclofen, a well-known GABA(B) receptor agonist, and it acts as a GABA(B)R1 antagonist, effectively blocking the receptor's activity. | ||||||